QA: AGILE THERAPEUTICS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2023_AGILE_THERAPEUTICS_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001261249, AGILE THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 11,358,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 177,000
3 remainder_Assets 2,707,000
4 LiabilitiesCurrent 13,387,000
5 LiabilitiesNoncurrent 466,000
6 remainder_Liabilities 5,934,000
7 CostOfGoodsAndServicesSold 6,836,000
8 SellingGeneralAndAdministrativeExpense 11,860,000
9 ResearchAndDevelopmentExpense 3,253,000
10 remainder_Expenses 36,816,000
11 remainder_Revenues 10,884,000
12 remainder_NetIncome 22,469,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,242,000
1 Liabilities 19,787,000
2 Expenses 58,765,000
3 Revenues 10,884,000
4 StockholdersEquity -5,545,000
5 NetIncome -25,412,000
6 ComprehensiveNetIncome -25,412,000
7 BaseVar 63,073,500
8 EconomicCapitalRatio -2.05

Edgar->Model Mapping

Feature Distribution

Change over Time